Mydecine Innovations Group (MYCOF) News Today $0.0040 0.00 (-31.03%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Mydecine Innovations Group Inc (MYCOF)December 19 at 12:08 AM | uk.investing.comMydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial StatementsNovember 22, 2024 | finanznachrichten.deMydecine Innovations Group Inc - Suspension of TradingOctober 10, 2024 | finanznachrichten.deMydecine Innovations Group Inc. (MYCOF)September 21, 2024 | finance.yahoo.comMydecine Innovations Group Inc - Mydecine Provides Bl-Weekly Status ReportMay 17, 2024 | finanznachrichten.deMydecine Provides Bl-Weekly Status ReportMay 16, 2024 | stockhouse.comMydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade OrderMay 4, 2024 | stockhouse.comMydecine Innovations Group Inc - Mydecine applies for management cease trade orderMay 3, 2024 | finanznachrichten.deMydecine Innovations Group Inc - Management cease trade orderMay 3, 2024 | finanznachrichten.deMydecine Innovations Group Inc (0NF0.BE)April 18, 2024 | finance.yahoo.comMydecine Innovations Group Inc (0NF0.MU)April 17, 2024 | finance.yahoo.comMydecine Innovations Group Inc. Announces Closing Of Share For Debt SettlementApril 17, 2024 | stockhouse.comMydecine Innovations Group Inc - SHARE FOR DEBT SETTLEMENTApril 9, 2024 | uk.finance.yahoo.comMydecine Innovations Group Inc - Mydecine Innovations Group Inc. Announces Closing of Share for Debt SettlementMarch 28, 2024 | uk.finance.yahoo.comMydecine Innovations Group Inc. Announces Share for Debt SettlementMarch 20, 2024 | finance.yahoo.comMydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of CompoundsFebruary 7, 2024 | finance.yahoo.comMydecine Innovations Group Announces Director ResignationFebruary 2, 2024 | finance.yahoo.comMydecine Innovations Group Inc - Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 CompoundDecember 18, 2023 | uk.finance.yahoo.comMydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 CompoundDecember 18, 2023 | finance.yahoo.comMydecine Innovations Group Inc.: Mydecine Announces Update Regarding the Special Access ProgramNovember 29, 2023 | finanznachrichten.deMydecine Announces Update Regarding the Special Access ProgramNovember 28, 2023 | finance.yahoo.comCanadian Securities Exchange Reports October 2023 Performance FiguresNovember 17, 2023 | finance.yahoo.comMydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription AgreementsOctober 31, 2023 | finance.yahoo.comMydecine Innovations Group Inc.: Mydecine Provides Q4 2023 Business UpdateOctober 26, 2023 | finanznachrichten.deMydecine Provides Q4 2023 Business UpdateOctober 26, 2023 | financialpost.comMydecine Innovations Group Inc Share Price (MYIG.PL)October 25, 2023 | lse.co.ukMydecine Innovations Group gearing up for human trials after completing Aquis listingOctober 16, 2023 | proactiveinvestors.comMydecine Innovations Group Inc - Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UKOctober 13, 2023 | finanznachrichten.dePsychedelic-Based Drugs Biotech Company Begins Trading On UK's AQSE Growth MarketOctober 12, 2023 | benzinga.comMydecine Innovations Group Inc.: Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UKOctober 12, 2023 | finanznachrichten.deMydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UKOctober 12, 2023 | finance.yahoo.comMydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEOOctober 5, 2023 | finance.yahoo.comMydecine Innovations Group Inc.: Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission DateSeptember 28, 2023 | finanznachrichten.deMydecine Innovations Announces Closing of Prospectus Supplement FinancingSeptember 19, 2023 | finance.yahoo.comMydecine Innovations Group Inc.: Mydecine Announces Conditional Approval of CSE ListingAugust 31, 2023 | finanznachrichten.deMydecine Announces Conditional Approval of CSE ListingAugust 30, 2023 | finance.yahoo.comMydecine Innovations Group Inc.: Mydecine Reports Financial Results for the Second Quarter of Fiscal Year 2023August 15, 2023 | finanznachrichten.deMydecine Reports Financial Results for the Second Quarter of Fiscal Year 2023August 14, 2023 | benzinga.comMydecine Reports Financial Results for the Second Quarter of Fiscal Year 2023August 14, 2023 | finance.yahoo.comMydecine Reports its Special Meeting ResultsJuly 5, 2023 | finance.yahoo.comMydecine's Prospectus Supplement Closing Under Share Subscription And Management UpdateMay 30, 2023 | msn.comMydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of DirectorsMay 29, 2023 | finance.yahoo.comMydecine's Q1 2023 Reports Shows Decline In Assets And R&D, Increase In Net Loss And Accumulated DeficitMay 17, 2023 | msn.comMydecine Innovations Group Inc.: Mydecine Reports Financial Results for the First Quarter of Fiscal Year 2023May 17, 2023 | finanznachrichten.deMydecine Reports Financial Results for the First Quarter of Fiscal Year 2023May 16, 2023 | finance.yahoo.comMydecine Reports its 2023 Annual General Shareholders' Meeting ResultsMay 10, 2023 | finance.yahoo.comNew Set Of MDMA Analogs To Hit The Clinic: These Are The Latest Positive FindingsApril 26, 2023 | msn.comMydecine Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting MDMA AnaloguesApril 24, 2023 | finance.yahoo.comMydecine Innovations Group Inc.April 21, 2023 | wsj.comMydecine: 2022 Financials & Business Update By Next-Gen Psychedelics Producer, Smoke Cessation Trial And MoreApril 3, 2023 | benzinga.com Get Mydecine Innovations Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MYCOF and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now MYCOF Media Mentions By Week MYCOF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYCOF News Sentiment▼0.000.60▲Average Medical News Sentiment MYCOF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYCOF Articles This Week▼10▲MYCOF Articles Average Week Get Mydecine Innovations Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MYCOF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Coca-Cola FEMSA News New Age Brands News Coca-Cola FEMSA News Coca-Cola Europacific Partners News Fomento Económico Mexicano News Celsius News Zevia PBC News Reed's News 1933 Industries News 4Front Ventures News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MYCOF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mydecine Innovations Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mydecine Innovations Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.